| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |